| JYSZ2200007 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2022-02-09 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSZ2200006 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2022-02-09 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSZ2200005 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2022-02-09 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSZ1700015 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2017-08-16 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2017-10-31 | view |
| JYSZ1700014 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2017-08-16 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2017-10-31 | view |
| JYSZ1700013 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2017-08-16 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2017-10-31 | view |
| JYSB2300064 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | Vetter Pharma-Fertigung Gmbh & Co KG;Roche Registration GmbH | | | view |
| JYSB2300052 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300051 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300050 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300041 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-04 | | Vetter Pharma-Fertigung Gmbh & Co KG;Roche Registration GmbH | | | view |
| JYSB2200190 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-10-10 | | Vetter Pharma-Fertigung Gmbh & Co KG;Roche Registration GmbH | | | view |
| JYSB2200158 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-08-23 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2200157 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-08-22 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2200156 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-08-22 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2000435 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-09-07 | | Chugai Pharma Manufacturing Co Ltd;Roche Pharma (Schweiz) Ltd | In Review | 2020-09-04 | view |
| JYSB2000434 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-09-07 | | Chugai Pharma Manufacturing Co Ltd;Roche Pharma (Schweiz) Ltd | In Review | 2020-09-04 | view |
| JYSB2000433 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-09-07 | | Chugai Pharma Manufacturing Co Ltd;Roche Pharma (Schweiz) Ltd | In Review | 2020-09-04 | view |
| JYSB2000408 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | | Chugai Pharma Manufacturing Co Ltd;Roche Pharma (Schweiz) Ltd | Filed | 2020-09-01 | view |
| JYSB2000407 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | | Chugai Pharma Manufacturing Co Ltd;Roche Pharma (Schweiz) Ltd | Filed | 2020-09-01 | view |
